Fate Therapeutics Inc.

NASDAQ: FATE
Share price (12/20/24): $1.68
Market cap (12/20/24): $191 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Redmile Group, LLC

Redmile Group, LLC, Green Jeremy

Point72 Asset Management, L.P.

Boxer Capital Management, LLC

News Filter

Announces Leadership Transition

Reports Third Quarter 2024 Financial Results and Business Updates

Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Second Quarter 2024 Financial Results and Business Updates

Appoints Neely Mozaffarian, MD, PhD, FACR, to Its Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness